Trump U-turned and stocks U-turned!
Yes, stock markets have lapped up the Trump U-turns on tariffs! We can only hope that the US President and his team of yes men and women have learnt this lesson
Switzer on Saturday, 26 April 2025
Thursday Edition, 24 April 2025
Time to take some profit on gold
While this precious metal rally may have further to run, some profit-taking is prudent, but hear me out why I say this.
“HOT” stock: Pinnacle Investment (PNI)
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why he expects Pinnacle Investment (PNI) to rally higher from here.
Two mid-tier gold producers
There are pockets of value still to be mined in the sector. Here are two mid-tier gold producers that fit the bill very nicely.
Questions of the Week
How can I protect my international shares against a rising Aussie dollar? Is Super Retail Group, which is paying a very attractive dividend, a “buy”? What do the brokers think of Technology One? Does the BOQ dividend reinvestment plan (DRP) issue shares at a discount?
Boom! Doom! Zoom! | 24th April 2025
Peter Switzer & Paul Rickard answer your questions on PME, VAS, MQG & more
Switzer on Saturday, 19 April 2025
It was Trump-v-Powell. Powell wins on points!
It’s a good sign that Wall Street was able to finish on a positive note, with all four most-watched indexes (i.e. the Dow, S&P 500, Nasdaq and Russell 2000) all ending up over 1%
Thursday Edition, 17 April 2025
Two strategies for investors desperately seeking income
Here’s an undervalued Listed Investment Company (LIC) to consider, and another idea for the watchlist.
“HOT” stock: Lynas Rare Earths (LYC)
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, says that with China banning the exports of rare earths to the US, Lynas Rare Earths (LYC) is a buy again.
Questions of the Week
Why is the rout in US Treasury Bonds impacting world markets? Why does RIO publish a quarterly production report? Do the brokers see more upside with MediBank Private? With oil stocks being slammed, is Woodside or Santos better value?
Boom! Doom! Zoom! | 17th April 2025
Peter Switzer & Paul Rickard answer your questions on AD8, TWE, BHP & more
Monday Edition, 14 April 2025
I’ll buy these 6 stocks
You never want a serious crisis to go to waste so let me tell you the six quality stocks I’ll be buying as soon as I think ‘normalcy’ is back.
Are these two high yielding stocks still in the “falling knife” category?
Let’s check out Spark New Zealand (SPK) and APA Group to determine if these two stocks are in the buy zone or should be dropped.
HOT” stock: Resmed (RMD)
In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk, gives us a rundown on what tariffs apply to various pharma stocks and which pharma he sees as an ADD to an investor’s portfolio.
Is CSL a buy?
The outlook for CSL (one of the few true global leaders on the ASX) from the analysts (who aren’t always right) is that the recent price decline gives investors an improved access point to a high-quality global healthcare exposure. Let’s put CSL under the microscope.